(PHILADELPHIA) – The Department
of Dermatology and the Abramson
Cancer Center of the University of Pennsylvania will
be conducting free screenings where a Penn dermatologist will
check people’s skin to determine their risk for developing
skin
cancer. Over 250 people are scheduled to receive a
free screening.
According to the American Cancer
Society, more than 1 million
new cases of skin cancer will be diagnosed in the U.S. this year,
and an estimated 10,850 people will die of skin cancer; 8,110 from
melanoma and 2,740 from other skin cancers. Additionally,
1 in 5 Americans will develop some form of skin cancer in their
lifetime. “Prevention and early detection are the keys
to protecting yourself from skin cancer,” says Chris
Miller, MD, Assistant Professor of Dermatology at Penn.
| WHEN: |
Friday May 18, 2007
12:30 – 4 p.m.
|
| WHERE: |
Department of Dermatology
Hospital of the University of
Pennsylvania [map]
Rhoads Pavilion, Second Floor [floor
plan]
3400 Spruce Street
Philadelphia, PA 19104
Note: No more appointments are available |
Editor's Note: If you plan on attending,
or would like to schedule an interview with Dr. Miller, please
call Kate Olderman at (215) 349-8369 or (215) 200-2312.
###
PENN Medicine is a $2.9 billion enterprise dedicated
to the related missions of medical education, biomedical research,
and high-quality patient care. PENN Medicine consists of the University
of Pennsylvania School of Medicine (founded in 1765 as the nation's
first medical school) and the University of Pennsylvania Health
System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S. News
& World Report's most recent ranking of top research-oriented
medical schools. Supporting 1,400 fulltime faculty and 700 students,
the School of Medicine is recognized worldwide for its superior
education and training of the next generation of physician-scientists
and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals,
all of which have received numerous national patient-care honors [Hospital
of the University of Pennsylvania; Pennsylvania Hospital, the nation's
first hospital; and Penn Presbyterian Medical Center]; a faculty practice
plan; a primary-care provider network; two multispecialty satellite
facilities; and home care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.